Preliminary clinical experience withcis-diamminedichloroplatinum (II) (NSC 119875, CACP)
Open Access
- 1 December 1972
- Vol. 30 (6) , 1451-1456
- https://doi.org/10.1002/1097-0142(197212)30:6<1451::aid-cncr2820300606>3.0.co;2-q
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Cross-linking of Complementary Strands of DNA in Mammalian Cells by Antitumour Platinum CompoundsNature, 1972
- Interaction of cis-dichlorodiammineplatinum (II) with DNABiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1971
- Antileukaemic and Nephrotoxic Properties of Platinum CompoundsNature, 1971
- cis-dichlorodiammineplatinum(II): Hematopoietic effects in ratsToxicology and Applied Pharmacology, 1971
- Cis-Dichlorodiammineplatinum [II]: Inhibition of Nucleic Acid Synthesis in Lymphocytes Stimulated with PhytohemagglutininExperimental Biology and Medicine, 1971
- CIS-dichlorodiammineplatinum (II)Biochemical Pharmacology, 1970
- Inhibitory effects of anti‐tumor platinum compounds on DNA, RNA and protein syntheses in mammalian cells in vitroInternational Journal of Cancer, 1970
- Platinum Compounds: a New Class of Potent Antitumour AgentsNature, 1969
- Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum ElectrodeNature, 1965